{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:06:35Z","timestamp":1793477195279,"version":"4.5.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,10,6]],"date-time":"2011-10-06T00:00:00Z","timestamp":1317859200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s11906-011-0231-x","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T23:24:05Z","timestamp":1317770645000},"page":"409-420","source":"Crossref","is-referenced-by-count":84,"title":["Effects of Relaxin on Arterial Dilation, Remodeling, and Mechanical Properties"],"prefix":"10.1007","volume":"13","author":[{"given":"Kirk P.","family":"Conrad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev G.","family":"Shroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,6]]},"reference":[{"key":"231_CR1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1210\/er.2003-0013","volume":"25","author":"OD Sherwood","year":"2004","unstructured":"Sherwood OD. Relaxin\u2019s physiological roles and other diverse actions. Endocr Rev. 2004;25:205\u201334.","journal-title":"Endocr Rev"},{"key":"231_CR2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1043-2760(03)00081-X","volume":"14","author":"RA Bathgate","year":"2003","unstructured":"Bathgate RA, Samuel CS, Burazin TC, et al. Relaxin: new peptides, receptors and novel actions. Trends Endocrinol Metabol. 2003;14:207\u201313.","journal-title":"Trends Endocrinol Metabol"},{"key":"231_CR3","first-page":"861","volume-title":"The physiology of reproduction","author":"OD Sherwood","year":"1994","unstructured":"Sherwood OD. Relaxin. In: Knobil E, Neill JD, Greenwald GS, Markert CL, Pfaff DW, editors. The physiology of reproduction. 2nd ed. New York: Raven; 1994. p. 861\u20131008.","edition":"2"},{"key":"231_CR4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.semnephrol.2010.10.003","volume":"31","author":"KP Conrad","year":"2011","unstructured":"Conrad KP. Emerging role of relaxin in the maternal adapations to normal pregnancy: implications for preeclampsia. Semin Nephrol. 2011;31:15\u201332.","journal-title":"Semin Nephrol"},{"key":"231_CR5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1210\/endo-81-2-375","volume":"81","author":"FL Hisaw","year":"1967","unstructured":"Hisaw FL, Hisaw Jr FL, Dawson AB. Effects of relaxin on the endothelium of endometrial blood vessels in monkeys (Macaca mulatta). Endocrinol. 1967;81:375\u201385.","journal-title":"Endocrinol"},{"key":"231_CR6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/aja.1001190105","volume":"119","author":"G Dallenbach-Hellweg","year":"1966","unstructured":"Dallenbach-Hellweg G, Dawson AB, Hisaw FL. The effect of relaxin on the endometrium of monkeys. Histological and histochemical studies. Am J Anat. 1966;119:61\u201378.","journal-title":"Am J Anat"},{"key":"231_CR7","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/0024-3205(85)90251-6","volume":"37","author":"J St-Louis","year":"1985","unstructured":"St-Louis J, Massicotte G. Chronic decrease of blood pressure by rat relaxin in spontaneously hypertensive rats. Life Sci. 1985;37:1351\u20137.","journal-title":"Life Sci"},{"key":"231_CR8","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1111\/j.1476-5381.1995.tb16377.x","volume":"116","author":"T Bani-Sacchi","year":"1995","unstructured":"Bani-Sacchi T, Bigazzi M, Bani D, et al. Relaxin-induced increased coronary flow through stimulation of nitric oxide production. Br J Pharmacol. 1995;116:1589\u201394.","journal-title":"Br J Pharmacol"},{"key":"231_CR9","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1210\/en.2003-1612","volume":"145","author":"KP Conrad","year":"2004","unstructured":"Conrad KP, Debrah DO, Novak J, et al. Relaxin modifies systemic arterial resistance and compliance in conscious, nonpregnant rats. Endocrinol. 2004;145:3289\u201396.","journal-title":"Endocrinol"},{"key":"231_CR10","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1152\/japplphysiol.01083.2004","volume":"98","author":"DO Debrah","year":"2005","unstructured":"Debrah DO, Conrad KP, Danielson LA, Shroff SG. Effects of relaxin on systemic arterial hemodynamics and mechanical properties in conscious rats: sex dependency and dose response. J Appl Physiol. 2005;98:1013\u201320.","journal-title":"J Appl Physiol"},{"key":"231_CR11","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1210\/en.2006-0567","volume":"147","author":"DO Debrah","year":"2006","unstructured":"Debrah DO, Novak J, Matthews JE, et al. Relaxin is essential for systemic vasodilation and increased global arterial compliance during early pregnancy in conscious rats. Endocrinol. 2006;147:5126\u201331.","journal-title":"Endocrinol"},{"key":"231_CR12","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1161\/01.HYP.0000184230.52059.33","volume":"46","author":"DO Debrah","year":"2005","unstructured":"Debrah DO, Conrad KP, Jeyabalan A, et al. Relaxin increases cardiac output and reduces systemic arterial load in hypertensive rats. Hypertension. 2005;46:745\u201350.","journal-title":"Hypertension"},{"key":"231_CR13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/B978-0-12-374213-1.00019-7","volume-title":"Chesley\u2019s hypertensive disorders in pregnancy","author":"P August","year":"2009","unstructured":"August P, Lindheimer MD. Chronic hypertension and pregnancy. In: Lindheimer MD, Roberts JM, Cunningham GF, editors. Chesley\u2019s hypertensive disorders in pregnancy. 3rd ed. San Diego: Academic; 2009. p. 353\u201368.","edition":"3"},{"key":"231_CR14","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1172\/JCI5630","volume":"103","author":"LA Danielson","year":"1999","unstructured":"Danielson LA, Sherwood OD, Conrad KP. Relaxin is a potent renal vasodilator in conscious rats. J Clin Invest. 1999;103:525\u201333.","journal-title":"J Clin Invest"},{"key":"231_CR15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ki.1984.129","volume":"26","author":"KP Conrad","year":"1984","unstructured":"Conrad KP. Renal hemodynamics during pregnancy in chronically catheterized, conscious rats. Kidney Int. 1984;26:24\u20139.","journal-title":"Kidney Int"},{"key":"231_CR16","first-page":"R1298","volume":"279","author":"LA Danielson","year":"2000","unstructured":"Danielson LA, Kercher LJ, Conrad KP. Impact of gender and endothelin on renal vasodilation and hyperfiltration induced by relaxin in conscious rats. Am J Physiol. 2000;279:R1298\u2013304.","journal-title":"Am J Physiol"},{"key":"231_CR17","first-page":"R349","volume":"283","author":"J Novak","year":"2002","unstructured":"Novak J, Ramirez RJ, Gandley RE, et al. Myogenic reactivity is reduced in small renal arteries isolated from relaxin-treated rats. Am J Physiol. 2002;283:R349\u201355.","journal-title":"Am J Physiol"},{"key":"231_CR18","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1152\/ajpcell.2001.280.1.C1","volume":"280","author":"RE Gandley","year":"2001","unstructured":"Gandley RE, Conrad KP, McLaughlin MK. Endothelin and nitric oxide mediate reduced myogenic reactivity of small renal arteries from pregnant rats. Am J Physiol. 2001;280:R1\u20137.","journal-title":"Am J Physiol"},{"key":"231_CR19","unstructured":"van Drongelen J, Pertijs J, Wouterse A et al. Contribution of different local vascular responses to mid-gestational vasodilation. Am J Obstet Gynecol 2011. Eub ahead of print."},{"key":"231_CR20","doi-asserted-by":"crossref","first-page":"H1609","DOI":"10.1152\/ajpheart.00360.2010","volume":"300","author":"J Drongelen van","year":"2011","unstructured":"van Drongelen J, Ploemen IH, Pertijs J, et al. Aging attenuates the vasodilator response to relaxin. Am J Physiol Heart Circ Physiol. 2011;300:H1609\u20131615.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"231_CR21","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1172\/JCI112282","volume":"77","author":"KP Conrad","year":"1986","unstructured":"Conrad KP, Colpoys MC. Evidence against the hypothesis that prostaglandins are the vasodepressor agents of pregnancy. Serial studies in chronically instrumented, conscious rats. J Clin Invest. 1986;77:236\u201345.","journal-title":"J Clin Invest"},{"key":"231_CR22","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1172\/JCI118059","volume":"96","author":"LA Danielson","year":"1995","unstructured":"Danielson LA, Conrad KP. Acute blockade of nitric oxide synthase inhibits renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats. J Clin Invest. 1995;96:482\u201390.","journal-title":"J Clin Invest"},{"key":"231_CR23","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.HYP.30.3.580","volume":"30","author":"J Novak","year":"1997","unstructured":"Novak J, Reckelhoff J, Bumgarner L, et al. Reduced sensitivity of the renal circulation to angiotensin II in pregnant rats. Hypertension. 1997;30:580\u20134.","journal-title":"Hypertension"},{"key":"231_CR24","doi-asserted-by":"crossref","first-page":"e4845","DOI":"10.1371\/journal.pone.0004845","volume":"4","author":"VM Ferreira","year":"2009","unstructured":"Ferreira VM, Gomes TS, Reis LA, et al. Receptor-induced dilatation in the systemic and intrarenal adaptation to pregnancy in rats. PLoS One. 2009;4:e4845.","journal-title":"PLoS One"},{"key":"231_CR25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1161\/HYPERTENSIONAHA.110.164392","volume":"58","author":"JM Sasser","year":"2011","unstructured":"Sasser JM, Molnar M, Baylis C. Relaxin ameliorates hypertension and increases nitric oxide metabolite excretion in angiotensin II but not N(\u03c9)-nitro-L-arginine methyl ester hypertensive rats. Hypertension. 2011;58:197\u2013204.","journal-title":"Hypertension"},{"key":"231_CR26","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1152\/japplphysiol.00545.2003","volume":"95","author":"LA Danielson","year":"2003","unstructured":"Danielson LA, Conrad KP. Time course and dose response of relaxin-mediated renal vasodilation, hyperfiltration, and changes in plasma osmolality in conscious rats. J Appl Physiol. 2003;95:1509\u201314.","journal-title":"J Appl Physiol"},{"key":"231_CR27","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cardfail.2009.01.008","volume":"15","author":"T Dschietzig","year":"2009","unstructured":"Dschietzig T, Teichman S, Unemori E, et al. Intravenous recombinant human relaxin in compensated heart failure: a safety, tolerability, and pharmacodynamic trial. J Card Fail. 2009;15:182\u201390.","journal-title":"J Card Fail"},{"key":"231_CR28","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1096\/fj.04-3664fje","volume":"19","author":"AM Perna","year":"2005","unstructured":"Perna AM, Masini E, Nistri S, et al. Novel drug development opportunity for relaxin in acute myocardial infarction: evidences from a swine model. FASEB J. 2005;19:1525\u20137.","journal-title":"FASEB J"},{"key":"231_CR29","first-page":"373","volume-title":"Proceedings of the Third International Conference on Relaxin and Related Peptides","author":"MS Erikson","year":"2001","unstructured":"Erikson MS, Unemori EN. Relaxin clinical trials in systemic sclerosis. In: Tregear GW, Ivell R, Bathgate RA, Wade JD, editors. Proceedings of the Third International Conference on Relaxin and Related Peptides. Dordrecht: Kluwer; 2001. p. 373\u201381."},{"key":"231_CR30","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/art.24380","volume":"60","author":"D Khanna","year":"2009","unstructured":"Khanna D, Clements PJ, Furst DE, et al. Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2009;60:1102\u201311.","journal-title":"Arthritis Rheum"},{"key":"231_CR31","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10741-008-9129-3","volume":"14","author":"SL Teichman","year":"2008","unstructured":"\u2022 Teichman SL, Unemori E, Dschietzig T, et al. Relaxin, a pleiotropic vasodilator for the treatment of heart failure. Heart Fail Rev. 2008;14:321\u20139. The vascular actions of relaxin may have therapeutic indications for pathologies of pregnancy such as preeclampsia, as well as for disorders in the nonpregnant population, including heart failure. This work is important because it summarizes the rationale and evidence for the use of relaxin as a therapeutic agent in heart failure.","journal-title":"Heart Fail Rev"},{"key":"231_CR32","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1681\/ASN.2005090950","volume":"17","author":"MC Smith","year":"2006","unstructured":"Smith MC, Danielson LA, Conrad KP, Davison JM. Influence of recombinant human relaxin on renal hemodynamics in healthy volunteers. J Am Soc Nephrol. 2006;17:3192\u20137.","journal-title":"J Am Soc Nephrol"},{"key":"231_CR33","first-page":"462","volume-title":"Renal and electrolyte disorders","author":"A Jeyabalan","year":"2010","unstructured":"Jeyabalan A, Conrad KP. Renal physiology and pathophysiology in pregnancy. In: Schrier RW, editor. Renal and electrolyte disorders. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2010. p. 462\u2013518.","edition":"7"},{"key":"231_CR34","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1172\/JCI11975","volume":"107","author":"J Novak","year":"2001","unstructured":"Novak J, Danielson LA, Kerchner LJ, et al. Relaxin is essential for renal vasodilation during pregnancy in conscious rats. J Clin Invest. 2001;107:1469\u201375.","journal-title":"J Clin Invest"},{"key":"231_CR35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.fertnstert.2005.11.070","volume":"86","author":"MC Smith","year":"2006","unstructured":"Smith MC, Murdoch AP, Danielson LA, et al. Relaxin has a role in establishing a renal response in pregnancy. Fertil Steril. 2006;86:253\u20135.","journal-title":"Fertil Steril"},{"key":"231_CR36","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0272-6386(87)80118-X","volume":"9","author":"KP Conrad","year":"1987","unstructured":"Conrad KP. Possible mechanisms for changes in renal hemodynamics during pregnancy: studies from animal models. Am J Kidney Dis. 1987;9:253\u20139.","journal-title":"Am J Kidney Dis"},{"key":"231_CR37","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/01.RES.52.3.352","volume":"52","author":"RM Rapoport","year":"1983","unstructured":"Rapoport RM, Murad F. Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP. Circ Res. 1983;52:352\u20137.","journal-title":"Circ Res"},{"key":"231_CR38","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/327524a0","volume":"327","author":"RM Palmer","year":"1987","unstructured":"Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524\u20136.","journal-title":"Nature"},{"key":"231_CR39","first-page":"R847","volume":"257","author":"KP Conrad","year":"1989","unstructured":"Conrad KP, Vernier KA. Plasma level, urinary excretion, and metabolic production of cGMP during gestation in rats. Am J Physiol. 1989;257:R847\u201353.","journal-title":"Am J Physiol"},{"key":"231_CR40","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1096\/fasebj.7.6.7682524","volume":"7","author":"KP Conrad","year":"1993","unstructured":"Conrad KP, Joffe GM, Kruszyna H, et al. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J. 1993;7:566\u201371.","journal-title":"FASEB J"},{"key":"231_CR41","first-page":"R254","volume":"271","author":"M Gellai","year":"1996","unstructured":"Gellai M, Fletcher T, Pullen M, Nambi P. Evidence for the existence of endothelin-B receptor subtypes and their physiological roles in the rat. Am J Physiol. 1996;271:R254\u2013261.","journal-title":"Am J Physiol"},{"key":"231_CR42","first-page":"F767","volume":"276","author":"KP Conrad","year":"1999","unstructured":"Conrad KP, Gandley RE, Ogawa T, et al. Endothelin mediates renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats. Am J Physiol. 1999;276:F767\u201376.","journal-title":"Am J Physiol"},{"key":"231_CR43","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1161\/01.HYP.33.1.435","volume":"33","author":"BT Alexander","year":"1999","unstructured":"Alexander BT, Miller MT, Kassab S, et al. Differential expression of renal nitric oxide synthase isoforms during pregnancy in rats. Hypertension. 1999;33:435\u20139.","journal-title":"Hypertension"},{"key":"231_CR44","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jsgi.2003.12.005","volume":"11","author":"J Novak","year":"2004","unstructured":"Novak J, Rajakumar A, Miles TM, Conrad KP. Nitric oxide synthase isoforms in the rat kidney during pregnancy. J Soc Gynecol Investig. 2004;11:280\u20138.","journal-title":"J Soc Gynecol Investig"},{"key":"231_CR45","doi-asserted-by":"crossref","first-page":"F830","DOI":"10.1152\/ajprenal.00300.2010","volume":"299","author":"CA Smith","year":"2010","unstructured":"Smith CA, Santymire B, Erdely A, et al. Renal nitric oxide production in rat pregnancy: role of constitutive nitric oxide synthases. Am J Physiol Renal Physiol. 2010;299:F830\u2013836.","journal-title":"Am J Physiol Renal Physiol"},{"key":"231_CR46","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1210\/en.2004-1602","volume":"146","author":"LJ Kerchner","year":"2005","unstructured":"Kerchner LJ, Novak J, Hanley-Yanez K, et al. Evidence against the hypothesis that endothelial endothelin B receptor expression is regulated by relaxin and pregnancy. Endocrinol. 2005;146:2791\u20137.","journal-title":"Endocrinol"},{"key":"231_CR47","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.RES.0000051884.27117.7E","volume":"92","author":"T Dschietzig","year":"2003","unstructured":"Dschietzig T, Bartsch C, Richter C, et al. Relaxin, a pregnancy hormone, is a functional endothelin-1 antagonist: attenuation of endothelin-1-mediated vasoconstriction by stimulation of endothelin type-B receptor expression via ERK-1\/2 and nuclear factor-kappaB. Circ Res. 2003;92:32\u201340.","journal-title":"Circ Res"},{"key":"231_CR48","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/01.RES.0000104086.43830.6C","volume":"93","author":"A Jeyabalan","year":"2003","unstructured":"Jeyabalan A, Novak J, Danielson LA, et al. Essential role for vascular gelatinase activity in relaxin-induced renal vasodilation, hyperfiltration, and reduced myogenic reactivity of small arteries. Circ Res. 2003;93:1249\u201357.","journal-title":"Circ Res"},{"key":"231_CR49","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1172\/JCI119099","volume":"98","author":"EN Unemori","year":"1996","unstructured":"Unemori EN, Pickford LB, Salles AL, et al. Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo. J Clin Invest. 1996;98:2739\u201345.","journal-title":"J Clin Invest"},{"key":"231_CR50","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1210\/en.142.8.3405","volume":"142","author":"S Palejwala","year":"2001","unstructured":"Palejwala S, Stein DE, Weiss G, et al. Relaxin positively regulates matrix metalloproteinase expression in human lower uterine segment fibroblasts using a tyrosine kinase signaling pathway. Endocrinology. 2001;142:3405\u201313.","journal-title":"Endocrinology"},{"key":"231_CR51","doi-asserted-by":"crossref","first-page":"10681","DOI":"10.1016\/S0021-9258(18)87000-4","volume":"265","author":"EN Unemori","year":"1990","unstructured":"Unemori EN, Amento EP. Relaxin modulates synthesis and secretion of procollagenase and collagen by human dermal fibroblasts. J Biol Chem. 1990;265:10681\u20135.","journal-title":"J Biol Chem"},{"key":"231_CR52","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1161\/01.RES.85.10.906","volume":"85","author":"C Fernandez-Patron","year":"1999","unstructured":"Fernandez-Patron C, Radomski MW, Davidge ST. Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor. Circ Res. 1999;85:906\u201311.","journal-title":"Circ Res"},{"key":"231_CR53","doi-asserted-by":"crossref","first-page":"H1473","DOI":"10.1152\/ajpheart.2000.278.5.H1473","volume":"278","author":"C Fernandez-Patron","year":"2000","unstructured":"Fernandez-Patron C, Radomski MW, Davidge ST. Role of matrix metalloproteinase-2 in thrombin-induced vasorelaxation of rat mesenteric arteries. Am J Physiol Heart Circ Physiol. 2000;278:H1473\u20131479.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"231_CR54","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/11703","volume":"17","author":"E Koivunen","year":"1999","unstructured":"Koivunen E, Arap W, Valtanen H, et al. Tumor targeting with a selective gelatinase inhibitor. Nat Biotechnol. 1999;17:768\u201374.","journal-title":"Nat Biotechnol"},{"key":"231_CR55","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1152\/japplphysiol.01330.2005","volume":"100","author":"A Jeyabalan","year":"2006","unstructured":"Jeyabalan A, Kerchner LJ, Fisher MC, et al. Matrix metalloproteinase-2 activity, protein, mRNA, and tissue inhibitors in small arteries from pregnant and relaxin-treated nonpregnant rats. J Appl Physiol. 2006;100:1955\u201363.","journal-title":"J Appl Physiol"},{"key":"231_CR56","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/humrep\/gah045","volume":"10","author":"BA Kelly","year":"2004","unstructured":"Kelly BA, Bond BC, Poston L. Aortic adaptation to pregnancy: elevated expression of matrix metalloproteinases-2 and \u22123 in rat gestation. Mol Hum Reprod. 2004;10:331\u20137.","journal-title":"Mol Hum Reprod"},{"key":"231_CR57","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1681\/ASN.2005121307","volume":"17","author":"LA Danielson","year":"2006","unstructured":"Danielson LA, Welford A, Harris A. Relaxin improves renal function and histology in aging Munich Wistar rats. J Am Soc Nephrol. 2006;17:1325\u201333.","journal-title":"J Am Soc Nephrol"},{"key":"231_CR58","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000119754","volume":"45","author":"HW Eijndhoven van","year":"2008","unstructured":"van Eijndhoven HW, Janssen GM, Aardenburg R, et al. Mechanisms leading to increased vasodilator responses to calcitonin-gene-related peptide in mesenteric resistance arteries of early pregnant rats. J Vasc Res. 2008;45:350\u20136.","journal-title":"J Vasc Res"},{"key":"231_CR59","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1161\/HYPERTENSIONAHA.110.165027","volume":"57","author":"JT McGuane","year":"2011","unstructured":"\u2022 McGuane JT, Danielson LA, Debrah JE, et al. Angiogenic growth factors are new and essential players in the sustained relaxin vasodilatory pathway in rodents and humans. Hypertension. 2011;57:1151\u201360. This article is one of the latest in a series further elucidating the mechanisms of relaxin-induced \u201csustained\u201d vasodilatory responses. It is significant because angiogenic growth factors are shown to be involved as molecular intermediates. The additional findings that \u201csustained\u201d relaxin-induced vasodilation is observed in rat and mouse small renal arteries and human subcutaneous arteries, with similar underlying molecular mechanisms, suggest some degree of species conservation, perhaps underscoring the biologic importance of the hormone.","journal-title":"Hypertension"},{"key":"231_CR60","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1210\/en.2006-0989","volume":"148","author":"A Jeyabalan","year":"2007","unstructured":"Jeyabalan A, Novak J, Doty KD, et al. Vascular matrix metalloproteinase-9 mediates the inhibition of myogenic reactivity in small arteries isolated from rats after short-term administration of relaxin. Endocrinol. 2007;148:189\u201397.","journal-title":"Endocrinol"},{"key":"231_CR61","first-page":"32","volume":"18","author":"J Novak","year":"2004","unstructured":"Novak J, Conrad KP. Small renal arteries isolated from ETB receptor deficient rats fail to exhibit the normal maternal adaptation to pregnancy [abstract]. FASEB J. 2004;18:32.","journal-title":"FASEB J"},{"issue":"1 suppl.","key":"231_CR62","first-page":"217A","volume":"15","author":"JE Debrah","year":"2008","unstructured":"Debrah JE, Agoulnik A, Conrad KP. Changes in arterial function by chronic relaxin infusion are mediated by the leucine rich repeat G coupled Lgr7 receptor [abstract]. Reprod Sci. 2008;15(1 Suppl):217A.","journal-title":"Reprod Sci"},{"key":"231_CR63","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1161\/01.CIR.0000025630.05387.45","volume":"106","author":"C Fisher","year":"2002","unstructured":"Fisher C, MacLean M, Morecroft I, et al. Is the pregnancy hormone relaxin also a vasodilator peptide secreted by the heart? Circulation. 2002;106:292\u20135.","journal-title":"Circulation"},{"key":"231_CR64","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1210\/en.2010-1126","volume":"152","author":"JT McGuane","year":"2011","unstructured":"\u2022 McGuane JT, Debrah JE, Sautina L, et al. Relaxin induces rapid dilation of rodent small renal and human subcutaneous arteries via PI3 kinase and nitric oxide. Endocrinology. 2011;152:2786\u201396. This publication investigates mechanisms of relaxin-induced \u201crapid\u201d vasodilation. Once again, the finding that \u201crapid\u201d relaxin-induced vasodilation is observed in rat and mouse small renal arteries and human subcutaneous arteries, and the similarity of the underlying molecular mechanisms (at least as tested in the rat and human) suggest some degree of species conservation, perhaps underscoring the biologic importance of the hormone.","journal-title":"Endocrinology"},{"key":"231_CR65","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1096\/fj.06-6263com","volume":"20","author":"J Novak","year":"2006","unstructured":"Novak J, Parry LJ, Matthews JE, et al. Evidence for local relaxin ligand-receptor expression and function in arteries. FASEB J. 2006;20:2352\u201362.","journal-title":"FASEB J"},{"key":"231_CR66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399405009944","volume":"7","author":"JT McGuane","year":"2005","unstructured":"McGuane JT, Parry LJ. Relaxin and the extracellular matrix: molecular mechanisms of action and implications for cardiovascular disease. Expert Rev Mol Med. 2005;7:1\u201318.","journal-title":"Expert Rev Mol Med"},{"key":"231_CR67","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3121\/cmr.3.4.241","volume":"3","author":"CS Samuel","year":"2005","unstructured":"Samuel CS. Relaxin: antifibrotic properties and effects in models of disease. Clin Med Res. 2005;3:241\u20139.","journal-title":"Clin Med Res"},{"key":"231_CR68","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.pharmthera.2005.05.012","volume":"112","author":"CS Samuel","year":"2006","unstructured":"Samuel CS, Du XJ, Bathgate RA, Summers RJ. \u2018Relaxin\u2019 the stiffened heart and arteries: the therapeutic potential for relaxin in the treatment of cardiovascular disease. Pharmacol Ther. 2006;112:529\u201352.","journal-title":"Pharmacol Ther"},{"key":"231_CR69","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/01.HYP.0000171930.00697.2f","volume":"46","author":"ED Lekgabe","year":"2005","unstructured":"Lekgabe ED, Kiriazis H, Zhao C, et al. Relaxin reverses cardiac and renal fibrosis in spontaneously hypertensive rats. Hypertension. 2005;46:412\u20138.","journal-title":"Hypertension"},{"key":"231_CR70","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1210\/en.2008-0250","volume":"149","author":"CS Samuel","year":"2008","unstructured":"Samuel CS, Hewitson TD, Zhang Y, Kelly DJ. Relaxin ameliorates fibrosis in experimental diabetic cardiomyopathy. Endocrinology. 2008;149:3286\u201393.","journal-title":"Endocrinology"},{"key":"231_CR71","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1749-6632.2008.03780.x","volume":"1160","author":"XJ Du","year":"2009","unstructured":"Du XJ, Xu Q, Lekgabe E, et al. Reversal of cardiac fibrosis and related dysfunction by relaxin. Ann N Y Acad Sci. 2009;1160:278\u201384.","journal-title":"Ann N Y Acad Sci"},{"key":"231_CR72","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/labinvest.2010.198","volume":"91","author":"CS Samuel","year":"2011","unstructured":"Samuel CS, Cendrawan S, Gao XM, et al. Relaxin remodels fibrotic healing following myocardial infarction. Lab Invest. 2011;91:675\u201390.","journal-title":"Lab Invest"},{"key":"231_CR73","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/HYPERTENSIONAHA.109.149369","volume":"55","author":"Q Xu","year":"2010","unstructured":"\u2022 Xu Q, Chakravorty A, Bathgate RA, et al. Relaxin therapy reverses large artery remodeling and improves arterial compliance in senescent spontaneously hypertensive rats. Hypertension. 2010;55:1260\u20136. This work provides evidence for relaxin\u2019s antifibrotic properties in the setting of established vascular fibrosis (senescent spontaneously hypertensive rats) and demonstrates the beneficial functional effects of the reduction in vascular fibrosis: increased in vivo global arterial compliance and increased ex vivo passive vascular compliance.","journal-title":"Hypertension"},{"key":"231_CR74","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1152\/japplphysiol.00845.2010","volume":"111","author":"DO Debrah","year":"2011","unstructured":"\u2022 Debrah DO, Debrah JE, Haney JL, et al. Relaxin regulates vascular wall remodeling and passive mechanical properties in mice. J Appl Physiol. 2011;111:260\u201371. This work comprehensively evaluates the contributions of vascular geometric and compositional remodeling to the relaxin-induced increase in ex vivo passive vascular compliance.","journal-title":"J Appl Physiol"},{"key":"231_CR75","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1096\/fj.10-175471","volume":"25","author":"SL Chan","year":"2011","unstructured":"\u2022 Chan SL, Cipolla MJ. Relaxin causes selective outward remodeling of brain parenchymal arterioles via activation of peroxisome proliferator-activated receptor-\u03b3. FASEB J. 2011;25:3229\u201339. This report is important because it implicates PPAR\u03b3 as a molecular mediator of relaxin-induced arterial remodeling.","journal-title":"FASEB J"},{"key":"231_CR76","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1152\/japplphysiol.01159.2010","volume":"110","author":"MJ Cipolla","year":"2011","unstructured":"Cipolla MJ, Sweet JG, Chan SL. Cerebral vascular adaptation to pregnancy and its role in the neurological complications of eclampsia. J Appl Physiol. 2011;110:329\u201339.","journal-title":"J Appl Physiol"},{"key":"231_CR77","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/01.RES.44.3.420","volume":"44","author":"M Pagani","year":"1979","unstructured":"Pagani M, Mirsky I, Baig H, et al. Effects of age on aortic pressure-diameter and elastic stiffness-stress relationships in unanesthetized sheep. Circ Res. 1979;44:420\u20139.","journal-title":"Circ Res"},{"key":"231_CR78","first-page":"R22","volume":"273","author":"RE Gandley","year":"1997","unstructured":"Gandley RE, Griggs KC, Conrad KP, McLaughlin MK. Intrinsic tone and passive mechanics of isolated renal arteries from virgin and late-pregnant rats. Am J Physiol. 1997;273:R22\u201327.","journal-title":"Am J Physiol"},{"key":"231_CR79","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/01.AOG.0000259316.04136.30","volume":"109","author":"UM Reddy","year":"2007","unstructured":"Reddy UM, Wapner RJ, Rebar RW, Tasca RJ. Infertility, assisted reproductive technology, and adverse pregnancy outcomes: executive summary of a National Institute of Child Health and Human Development workshop. Obstet Gynecol. 2007;109:967\u201377.","journal-title":"Obstet Gynecol"},{"key":"231_CR80","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1097\/01.ASN.0000135975.90889.60","volume":"15","author":"JM Davison","year":"2004","unstructured":"Davison JM, Homuth V, Jeyabalan A, et al. New aspects in the pathophysiology of preeclampsia. J Am Soc Nephrol. 2004;15:2440\u20138.","journal-title":"J Am Soc Nephrol"},{"key":"231_CR81","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.regpep.2010.09.001","volume":"166","author":"A Brecht","year":"2011","unstructured":"Brecht A, Bartsch C, Baumann G, et al. Relaxin inhibits early steps in vascular inflammation. Regul Pept. 2011;166:76\u201382.","journal-title":"Regul Pept"},{"key":"231_CR82","doi-asserted-by":"crossref","unstructured":"Segal MS, Sautina L, Li S et al. Relaxin increases human endothelial progenitor cell NO and migration and vasculogenesis in mice. Blood 2011; in press.","DOI":"10.1182\/blood-2011-04-346007"},{"key":"231_CR83","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","volume":"111","author":"SE Maynard","year":"2003","unstructured":"Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111:649\u201358.","journal-title":"J Clin Invest"},{"key":"231_CR84","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1749-6632.2008.03794.x","volume":"1160","author":"G Weiss","year":"2009","unstructured":"Weiss G, Teichman S, Stewart D, et al. A randomized, double-blind, placebo-controlled trial of relaxin for cervical ripening in post-delivery date pregnancies. Ann N Y Acad Sci. 2009;1160:385\u20136.","journal-title":"Ann N Y Acad Sci"},{"key":"231_CR85","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/01.CIR.0000048892.83521.58","volume":"107","author":"EG Lakatta","year":"2003","unstructured":"Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a \u201cset up\u201d for vascular disease. Circulation. 2003;107:139\u201346.","journal-title":"Circulation"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-011-0231-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-011-0231-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-011-0231-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T19:26:48Z","timestamp":1638991608000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-011-0231-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,6]]},"references-count":85,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["231"],"URL":"https:\/\/doi.org\/10.1007\/s11906-011-0231-x","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,6]]}}}